- Home
- TOI vs LTRN Comparison
TOI vs LTRN Comparison
Compare TOI & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOI
- LTRN
- Stock Information
- Founded
- TOI 2007
- LTRN 2013
- Country
- TOI United States
- LTRN United States
- Employees
- TOI N/A
- LTRN N/A
- Industry
- TOI Medical/Nursing Services
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- TOI Health Care
- LTRN Health Care
- Exchange
- TOI Nasdaq
- LTRN Nasdaq
- Market Cap
- TOI 49.1M
- LTRN 46.7M
- IPO Year
- TOI N/A
- LTRN 2020
- Fundamental
- Price
- TOI $1.14
- LTRN $3.54
- Analyst Decision
- TOI
- LTRN Hold
- Analyst Count
- TOI 0
- LTRN 1
- Target Price
- TOI N/A
- LTRN N/A
- AVG Volume (30 Days)
- TOI 558.9K
- LTRN 27.6K
- Earning Date
- TOI 03-24-2025
- LTRN 03-27-2025
- Dividend Yield
- TOI N/A
- LTRN N/A
- EPS Growth
- TOI N/A
- LTRN N/A
- EPS
- TOI N/A
- LTRN N/A
- Revenue
- TOI $393,412,000.00
- LTRN N/A
- Revenue This Year
- TOI $23.95
- LTRN N/A
- Revenue Next Year
- TOI N/A
- LTRN N/A
- P/E Ratio
- TOI N/A
- LTRN N/A
- Revenue Growth
- TOI 21.33
- LTRN N/A
- 52 Week Low
- TOI $0.13
- LTRN $2.79
- 52 Week High
- TOI $1.63
- LTRN $9.96
- Technical
- Relative Strength Index (RSI)
- TOI 64.39
- LTRN 39.55
- Support Level
- TOI $0.97
- LTRN $3.62
- Resistance Level
- TOI $1.34
- LTRN $4.00
- Average True Range (ATR)
- TOI 0.17
- LTRN 0.24
- MACD
- TOI 0.04
- LTRN -0.00
- Stochastic Oscillator
- TOI 63.83
- LTRN 22.93
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.